HIM
ETON icon

Hillsdale Investment Management’s Eton Pharmaceutcials ETON Stock Holding History

Hillsdale Investment Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,503
Closed -$402K – 691
2025
Q3 		$402K Sell
18,503
-400
-2% -$6.64K 0.01% 439
2025
Q2 		$269K Sell
18,903
-80
-0.4% -$1.26K 0.01% 444
2025
Q1 		$246K Buy
18,983
+1,980
+12% +$29.9K 0.01% 409
2024
Q4 		$226K Buy
+17,003
New +$172K 0.01% 401
2023
Q4 		– Sell
-28,800
Closed -$120K – 589
2023
Q3 		$120K Buy
+28,800
New +$111K 0.01% 390

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Hillsdale Investment Management's ETON Position: Q4 2025 in Review

Hillsdale Investment Management sold out of Eton Pharmaceutcials (ETON) in Q4 2025, closing a stake of 18,503 shares — an estimated $402K sold.

Hillsdale Investment Management first reported a position in ETON in Q3 2023 and held it in 5 quarters. The position peaked at $402K in Q3 2025. 104 funds tracked by Wall St. Rank hold ETON as of Q4 2025.

  • Hillsdale Investment Management reported no remaining Eton Pharmaceutcials position as of Q4 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 18,503 Eton Pharmaceutcials shares in Q4 2025, an estimated $402K.
  • Hillsdale Investment Management first reported a position in Eton Pharmaceutcials in Q3 2023 and held it in 5 quarters.
  • Hillsdale Investment Management's Eton Pharmaceutcials position peaked at $402K in Q3 2025.
  • 104 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q4 2025.

Based on Hillsdale Investment Management's 13F filing for Q4 2025, filed 10 Feb 2026.